Bluebird Bio (BLUE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | BLUE | BMY | AMGN | GSK | GILD |
| Company | Bluebird Bio | Bristol-Myers Squibb Company | Amgen Inc | Gsk Plc ADR | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NYSE | NASDAQ |
| Open | 0.5180 | 49.89 | 337.03 | 42.40 | 84.39 |
| High | 0.5180 | 50.04 | 338.70 | 42.42 | 84.65 |
| Low | 0.4869 | 49.11 | 334.61 | 41.46 | 83.57 |
| Last | 0.4815 | 49.21 | 335.66 | 41.72 | 83.64 |
| Change | -0.0135 | -0.53 | +2.74 | -0.71 | -0.25 |
| % Change | -2.73% | -1.07% | +0.82% | -1.67% | -0.30% |
| Volume | 2,965,359 | 3,960,924 | 812,082 | 4,811,326 | 4,961,288 |
| 20-Day Average Volume | 7,436,951 | 8,355,864 | 1,718,224 | 3,657,418 | 6,492,324 |
| Previous Close | 0.4950 | 49.74 | 332.92 | 42.43 | 83.89 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.5819 | 49.12 | 329.65 | 43.28 | 80.09 |
| 20-Day Raw Stochastic | 5.67% | 69.02% | 90.72% | 12.97% | 93.50% |
| 20-Day Relative Strength | 33.97% | 56.66% | 58.54% | 48.16% | 72.58% |
| Weighted Alpha | -73.87 | -9.86 | +27.72 | +10.99 | +18.96 |
| Today's Opinion | 100% Sell | 72% Buy | 96% Buy | 48% Buy | 88% Buy |
| Previous Opinion | 100% Sell | 72% Buy | 88% Buy | 56% Buy | 88% Buy |
| Last Month's Opinion | 100% Sell | 40% Buy | 88% Buy | 40% Buy | 56% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -13.75% since 09/12/24 | +2.72% since 09/12/24 | +2.15% since 09/12/24 | -2.84% since 09/12/24 | +1.33% since 09/12/24 |
| Low | 0.4800 on 09/17/24 | 48.20 on 09/13/24 | 327.15 on 09/13/24 | 41.47 on 09/19/24 | 81.57 on 09/13/24 |
| High | 0.6300 on 09/16/24 | 50.41 on 09/17/24 | 339.00 on 09/18/24 | 43.62 on 09/16/24 | 84.65 on 09/19/24 |
| 1-Month | |||||
| %Chg | -28.44% since 08/19/24 | +0.51% since 08/19/24 | +2.80% since 08/19/24 | +0.88% since 08/19/24 | +13.19% since 08/19/24 |
| Low | 0.4800 on 09/17/24 | 46.88 on 08/22/24 | 319.00 on 09/06/24 | 41.47 on 09/19/24 | 74.34 on 08/20/24 |
| High | 0.7463 on 08/22/24 | 50.75 on 09/04/24 | 339.00 on 09/18/24 | 44.67 on 08/27/24 | 84.89 on 09/12/24 |
| 3-Month | |||||
| %Chg | -45.63% since 06/18/24 | +21.42% since 06/18/24 | +10.18% since 06/18/24 | +2.28% since 06/18/24 | +33.44% since 06/18/24 |
| Low | 0.4800 on 09/17/24 | 39.35 on 07/05/24 | 303.55 on 06/20/24 | 37.81 on 07/02/24 | 64.86 on 06/20/24 |
| High | 1.4300 on 07/16/24 | 51.19 on 07/29/24 | 346.85 on 07/25/24 | 44.67 on 08/27/24 | 84.89 on 09/12/24 |
| 6-Month | |||||
| %Chg | -64.64% since 03/19/24 | -4.34% since 03/19/24 | +24.07% since 03/19/24 | -1.03% since 03/19/24 | +14.79% since 03/19/24 |
| Low | 0.4800 on 09/17/24 | 39.35 on 07/05/24 | 260.68 on 04/19/24 | 37.81 on 07/02/24 | 62.07 on 05/31/24 |
| High | 1.4900 on 03/21/24 | 54.47 on 03/28/24 | 346.85 on 07/25/24 | 45.92 on 05/15/24 | 84.89 on 09/12/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 54,121 | 100,827,960 | 178,589,936 | 87,935,408 | 104,514,608 |
| Shares Outstanding, K | 109,336 | 2,027,100 | 536,435 | 2,072,482 | 1,245,853 |
| Annual Sales | 29,500,000 | 45,006,000,000 | 28,190,000,000 | 37,725,000,000 | 27,116,000,000 |
| Annual Net Income | -211,910,000 | 8,025,000,000 | 6,717,000,000 | 6,129,940,000 | 5,665,000,000 |
| Last Quarter Sales | 18,570,000 | 12,201,000,000 | 8,388,000,000 | 9,950,400,000 | 6,954,000,000 |
| Last Quarter Net Income | -69,800,000 | 1,680,000,000 | 746,000,000 | 1,480,440,000 | 1,614,000,000 |
| 60-Month Beta | 0.75 | 0.46 | 0.61 | 0.66 | 0.18 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.36 on 09/13/24 | 2.07 on 07/26/24 | 4.97 on 08/06/24 | 1.09 on 07/31/24 | 2.01 on 08/08/24 |
| Latest Earnings Date | 08/14/24 | 10/31/24 | 10/29/24 | 11/06/24 | 11/05/24 |
| Most Recent Dividend | N/A | 0.600 on 07/05/24 | 2.250 on 08/16/24 | 0.378 on 08/16/24 | 0.770 on 09/13/24 |
| Next Ex-Dividends Date | N/A | 10/04/24 | 08/16/24 | 08/16/24 | 09/13/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 36.12 | 17.89 | 10.23 | 17.67 |